{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04557228",
            "orgStudyIdInfo": {
                "id": "2025921"
            },
            "organization": {
                "fullName": "University of Missouri-Columbia",
                "class": "OTHER"
            },
            "briefTitle": "ADAM17 and Vascular Function in Diabetes",
            "officialTitle": "Targeting ADAM17 Activity for Correction of Vascular Insulin Resistance in Type 2 Diabetes",
            "acronym": "ADAM17",
            "therapeuticArea": [
                "Endocrinology"
            ],
            "study": "and-vascular-function-in-diabetes"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-03-17",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-06-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-11-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-09-08",
            "studyFirstSubmitQcDate": "2020-09-14",
            "studyFirstPostDateStruct": {
                "date": "2020-09-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-17",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-19",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Luis Martinez-Lemus, DVM, PhD",
                "investigatorTitle": "Professor in Medical Pharmacology Physiology",
                "investigatorAffiliation": "University of Missouri-Columbia"
            },
            "leadSponsor": {
                "name": "University of Missouri-Columbia",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The objective of this project is to determine the extent to which administration of the dietary supplement phosphatidylserine (PS), a competitive inhibitor of ADAM17 sheddase activity, effects vascular function and insulin-stimulated leg blood flow in subjects with T2D.",
            "detailedDescription": "As part of a randomized (1:1, experimental/placebo), double-blinded parallel design, each of the 34 subjects will complete 4 weeks (+/-4 days) of supplementation with either 900mg of a PS supplement or placebo. Assessment visits (2) will occur pre-intervention and post-intervention and include: 24-hour ambulatory blood pressure measurement (ABPM), Vitals, DEXA scan for body composition, fasting blood work, carotid-femoral pulse wave velocity (cfPWV), brachial and femoral artery FMDs, Femoral blood flow imaging during passive leg movement (PLM), glycocalyx integrity assessment via Glycocheck, and an oral glucose tolerance test (OGTT) with blood flow measurements and beat-to-beat sphygmomanometry via Finometer."
        },
        "conditionsModule": {
            "conditions": [
                "Diabetes Mellitus, Type 2"
            ],
            "keywords": [
                "endothelial dysfunction",
                "vascular function"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Randomized, double-blinded design with 34 subjects",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 34,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Study participants will receive 4 weeks of supplementation with 900mg placebo supplements",
                    "interventionNames": [
                        "Dietary Supplement: Placebo"
                    ]
                },
                {
                    "label": "Phosphatidylserine Supplementation",
                    "type": "EXPERIMENTAL",
                    "description": "Study participants will receive 4 weeks of supplementation with 900mg phosphatidylserine supplements.",
                    "interventionNames": [
                        "Dietary Supplement: Phosphatidylserine"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIETARY_SUPPLEMENT",
                    "name": "Placebo",
                    "description": "4 weeks of placebo supplements",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                },
                {
                    "type": "DIETARY_SUPPLEMENT",
                    "name": "Phosphatidylserine",
                    "description": "4 weeks of phosphatidylserine supplements",
                    "armGroupLabels": [
                        "Phosphatidylserine Supplementation"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in Insulin-stimulated blood flow",
                    "description": "Measure of blood flow during oral glucose tolerance test. Leg blood flow measures will be performed non-invasively via Ultrasound.",
                    "timeFrame": "baseline and 4 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in Vascular function",
                    "description": "Flow mediated dilation (FMD) in arm and passive limb movement (PLM) in the leg. Blood flow measures will be performed non-invasively via Ultrasound.",
                    "timeFrame": "Baseline and 4 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Men and women with a BMI of 25-39 kg/m2, who are 45-64 years of age at randomization.\n2. T2D patients classified based on physician diagnosis.\n3. No vulnerable populations (e.g., prisoners, pregnant, children) will be enrolled.\n\nExclusion Criteria:\n\n1. Cardiovascular disease including myocardial infraction, heart failure, coronary artery disease, stroke\n2. History of chronic renal or hepatic disease\n3. Active cancer\n4. Autoimmune diseases\n5. Immunosuppressant therapy\n6. Hormone replacement therapy\n7. Excessive alcohol consumption (\\>14 drinks/week for men, \\>7 drinks/week for women)\n8. Current tobacco use\n9. Pregnancy\n10. Bodyweight change \u22655% within the last 6 months",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "45 Years",
            "maximumAge": "64 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Luis Martinez-Lemus, PhD",
                    "role": "CONTACT",
                    "phone": "(573) 882-3244",
                    "email": "martinezlemusl@missouri.edu"
                },
                {
                    "name": "Jaume Padilla, PhD",
                    "role": "CONTACT",
                    "phone": "(573) 882-7056",
                    "email": "padillaja@missouri.edu"
                }
            ],
            "locations": [
                {
                    "facility": "University of Missouri- NextGen Clinical Translational Science Unit",
                    "status": "RECRUITING",
                    "city": "Columbia",
                    "state": "Missouri",
                    "zip": "65212",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Luis A Martinez-Lemus, PhD",
                            "role": "CONTACT",
                            "phone": "573-882-3244",
                            "email": "martinezlemusl@missouri.edu"
                        },
                        {
                            "name": "Jaume Padilla, PhD",
                            "role": "CONTACT",
                            "phone": "(573) 882-7056",
                            "email": "padillaja@missouri.edu"
                        },
                        {
                            "name": "Luis A Martinez-Lemus, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Jaume Padilla, PhD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Camila M Manrique, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.95171,
                        "lon": -92.33407
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                },
                {
                    "id": "D000003924",
                    "term": "Diabetes Mellitus, Type 2"
                }
            ],
            "ancestors": [
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7119",
                    "name": "Diabetes Mellitus, Type 2",
                    "asFound": "Diabetes Mellitus, Type 2",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "asFound": "Diabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10370",
                    "name": "Insulin Resistance",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M10365",
                    "name": "Insulin",
                    "relevance": "LOW"
                },
                {
                    "id": "M173166",
                    "name": "Insulin, Globin Zinc",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Hypo",
                    "name": "Hypoglycemic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}